$ARIA Recent Headlines 6 stocks to watch 3:34 p.
Post# of 145170
Posted On: 02/21/2014 9:50:51 AM
$ARIA Recent Headlines
6 stocks to watch 3:34 p.m. Feb. 12, 2014 - The Trading Deck
Ariad falls after wild ride upward, while Care.com holds on to its gains 9:02 p.m. Jan. 27, 2014 - Russ Britt
Apple green ahead of earnings; Caterpillar tops gainers 3:42 p.m. Jan. 27, 2014 - Sue Chang
Ariad shares jump nearly 30% on rumors of Big Pharma takeover 1:43 p.m. Jan. 24, 2014 - Russ Britt
5 charts to watch 3:52 p.m. Jan. 15, 2014 - The Trading Deck
Apple closes lower; B. of A. rises on analyst call 4:15 p.m. Jan. 2, 2014 - Wallace Witkowski
Apple gains on China Mobile deal; homebuilders rally 3:33 p.m. Dec. 23, 2013 - Wallace Witkowski
Suspension is lifted for Ariad's leukemia drug 6:33 a.m. Dec. 23, 2013 - MarketWatch.com
J.C. Penney and more of the year's most profitable shorts 3:23 p.m. Dec. 9, 2013 - blogs.marketwatch.com
Hewlett-Packard, a cyclical green light and why silver is in trouble 8:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 12:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 3:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 10:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 7:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 7:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 3:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 10:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 1:06 p.m. Dec. 14, 2012 - MarketWatch.com
Stocks: Investors play the waiting game 8:53 a.m. Dec. 11, 2012 - The Trading Deck
New positions from top healthcare stockpickers 3:51 p.m. Feb. 19, 2014 - Seeking Alpha
An Overview Of Ariad Pharmaceuticals 10:22 a.m. Feb. 19, 2014 - Seeking Alpha
Ohr Pharmaceutical (OHRP) Catches Eye: Stock Rises 10.2% - Tale of the Tape 9:25 a.m. Feb. 19, 2014 - Zacks.com
Lannett (ACO) Worth Watching: Stock Rises 6.1% - Tale of the Tape 9:25 a.m. Feb. 14, 2014 - Zacks.com
Ariad Pharmaceuticals (ARIA): Today's Pre-Market Leader Stock 7:52 a.m. Feb. 14, 2014 - TheStreet.com
Ariad - An Options Trade On An Uncertain Forecast 10:00 a.m. Feb. 11, 2014 - Seeking Alpha
Stock To Watch: Ariad Pharmaceuticals (ARIA) In Perilous Reversal 9:45 a.m. Feb. 10, 2014 - TheStreet.com
Ariad Pharmaceuticals: Long-Term Prospects Of The Biotech Beauty Contest 4:59 a.m. Feb. 10, 2014 - Seeking Alpha
You Can No Longer Ignore Biotech 4:32 p.m. Feb. 7, 2014 - GuruFocus.com
Credit Suisse Reports Ariad's Iclusig is 'Essential Drug' 1:46 p.m. Feb. 7, 2014 - benzinga.com
Mettler-Toledo (MTD) Catches Eye: Stock Jumps 7.7% - Tale of the Tape 9:25 a.m. Feb. 7, 2014 - Zacks.com
Ariad +5.3% AH; activist investor reportedly wants board seats 5:20 p.m. Feb. 6, 2014 - Seeking Alpha
USANA Health Sciences (USNA) Worth Watching: Stock Soars 17.4% - Tale of the Tape 9:46 a.m. Feb. 6, 2014 - Zacks.com
'Mad Money' Lightning Round: We Don't Want Molycorp 6:00 a.m. Feb. 6, 2014 - TheStreet.com
Cramer's Lightning Round - If I Want Security, I Want Palo Alto (2/5/14) 5:57 a.m. Feb. 6, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: A Matter of Distrust 7:51 p.m. Feb. 5, 2014 - TheStreet.com
Ariad Pharma's Executive Stock Giveaway Kills Takeover Hopes 8:00 a.m. Feb. 5, 2014 - TheStreet.com
Investors are betting against Ariad Pharmaceuticals (ARIA), Should You? - Tale of the Tape 6:59 a.m. Feb. 4, 2014 - Zacks.com
Ohr Pharmaceutical (OHRP) Catches Eye: Stock Up 5.0% - Tale of the Tape 9:25 a.m. Feb. 3, 2014 - Zacks.com
Pre-Market Laggard: Ariad Pharmaceuticals (ARIA) 8:16 a.m. Feb. 3, 2014 - TheStreet.com
ARIAD Expands Its Board of Directors with Appointment of Alexander J. Denner, Ph.D. of Sarissa Capital Management 7:35 a.m. Today - BusinessWire - BZX
Facebook to Buy Messaging App WhatsApp; Garmin Ltd. Hits New 1-year High on Earnings 12:29 a.m. Feb. 20, 2014 - ACCESSWIRE
ARIAD to Present at the RBC Capital Markets Healthcare Conference 7:35 a.m. Feb. 19, 2014 - BusinessWire - BZX
ARIAD to Host Conference Call and Webcast Discussion of Fourth Quarter and Year-End 2013 Financial Results on February 25, 2014 7:35 a.m. Feb. 10, 2014 - BusinessWire - BZX
TrendingWallStreet.com Announces Coverage on DDD, ARIA, ENIP, and LATF 12:24 a.m. Feb. 6, 2014 - ACCESSWIRE
ARIAD to Present at the Leerink Swann Global Healthcare Conference 7:35 a.m. Feb. 5, 2014 - BusinessWire - BZX
ARIAD Announces Commercial Agreement for Iclusig (Ponatinib) in Australia 7:35 a.m. Jan. 28, 2014 - BusinessWire - BZX
ARIAD Announces the Commercial Availability of Iclusig (Ponatinib) for Patients with Refractory Philadelphia-Positive Leukemias in the U.S. 7:35 a.m. Jan. 17, 2014 - BusinessWire - BZX
Divestiture, Service Deployment, Executive Promotion, Updated Outlook, and Designation Granted-Research Report on Endo, ARIAD, Align Technology, PAREXEL, and The Medicines Company 8:00 a.m. Jan. 16, 2014 - PR Newswire - PRF
ARIAD and Medinol Announce Initiation of Two Registration Trials of the NIRsupreme™ Ridaforolimus-Eluting Stent for Use in Coronary Artery Disease 7:35 a.m. Jan. 14, 2014 - BusinessWire - BZX
Biologics Selected by ARIAD to Be the Exclusive Specialty Pharmacy Provider for Iclusig (ponatinib) 7:30 a.m. Jan. 13, 2014 - BusinessWire - BZX
Notable Buzzers: Ariad Pharmaceuticals, Twitter Inc, Facebook Inc, Qihoo 360 Technology 11:10 a.m. Jan. 8, 2014 - ACCESSWIRE
Conferences, Completed Acquisitions, and Stock Price Movements - Research Report on Ariad, Salix, Molina, Mednax, and Merrimack 8:00 a.m. Jan. 7, 2014 - PR Newswire
Morning Buzzers: Apple Inc, Plug Power Inc, Ariad Pharmaceuticals, Biodel Inc 10:01 a.m. Jan. 3, 2014 - ACCESSWIRE
ARIAD to Present at the 32nd Annual J.P. Morgan Healthcare Conference 7:34 a.m. Jan. 2, 2014 - BusinessWire
FDA Approvals, Stock Price Movements, and Acquisitions - Research Report on ARIAD, Gentium, Salix Pharmaceuticals, NPS Pharmaceuticals, and MEDNAX 8:00 a.m. Dec. 25, 2013 - PR Newswire
Insider Catalyst Report: Ariad Pharmaceuticals, Advanced Micro Devices, Petroleo Brasileiro Petrobras, Endeavor IP Inc 10:32 a.m. Dec. 23, 2013 - ACCESSWIRE
Stock Price Updates, Executive Appointments, Acquisitions, Orphan Drug Designations, and Preclinical Developments - Research Report on Ariad, Halozyme, DepoMed, Omeros, and BioCryst 8:00 a.m. Dec. 23, 2013 - PR Newswire
Technical Research on Equities: Ariad Pharma, MannKind, Galena Biopharma, and Novavax 8:00 a.m. Dec. 23, 2013 - PR Newswire
Bullish Trend Analysis: Ariad Pharmaceuticals, Federal Home Loan Mortgage Corp, NQ Mobile Inc, Micron Technology 11:02 a.m. Dec. 20, 2013 - ACCESSWIRE
6 stocks to watch 3:34 p.m. Feb. 12, 2014 - The Trading Deck
Ariad falls after wild ride upward, while Care.com holds on to its gains 9:02 p.m. Jan. 27, 2014 - Russ Britt
Apple green ahead of earnings; Caterpillar tops gainers 3:42 p.m. Jan. 27, 2014 - Sue Chang
Ariad shares jump nearly 30% on rumors of Big Pharma takeover 1:43 p.m. Jan. 24, 2014 - Russ Britt
5 charts to watch 3:52 p.m. Jan. 15, 2014 - The Trading Deck
Apple closes lower; B. of A. rises on analyst call 4:15 p.m. Jan. 2, 2014 - Wallace Witkowski
Apple gains on China Mobile deal; homebuilders rally 3:33 p.m. Dec. 23, 2013 - Wallace Witkowski
Suspension is lifted for Ariad's leukemia drug 6:33 a.m. Dec. 23, 2013 - MarketWatch.com
J.C. Penney and more of the year's most profitable shorts 3:23 p.m. Dec. 9, 2013 - blogs.marketwatch.com
Hewlett-Packard, a cyclical green light and why silver is in trouble 8:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 12:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 3:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 10:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 7:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 7:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 3:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 10:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 1:06 p.m. Dec. 14, 2012 - MarketWatch.com
Stocks: Investors play the waiting game 8:53 a.m. Dec. 11, 2012 - The Trading Deck
New positions from top healthcare stockpickers 3:51 p.m. Feb. 19, 2014 - Seeking Alpha
An Overview Of Ariad Pharmaceuticals 10:22 a.m. Feb. 19, 2014 - Seeking Alpha
Ohr Pharmaceutical (OHRP) Catches Eye: Stock Rises 10.2% - Tale of the Tape 9:25 a.m. Feb. 19, 2014 - Zacks.com
Lannett (ACO) Worth Watching: Stock Rises 6.1% - Tale of the Tape 9:25 a.m. Feb. 14, 2014 - Zacks.com
Ariad Pharmaceuticals (ARIA): Today's Pre-Market Leader Stock 7:52 a.m. Feb. 14, 2014 - TheStreet.com
Ariad - An Options Trade On An Uncertain Forecast 10:00 a.m. Feb. 11, 2014 - Seeking Alpha
Stock To Watch: Ariad Pharmaceuticals (ARIA) In Perilous Reversal 9:45 a.m. Feb. 10, 2014 - TheStreet.com
Ariad Pharmaceuticals: Long-Term Prospects Of The Biotech Beauty Contest 4:59 a.m. Feb. 10, 2014 - Seeking Alpha
You Can No Longer Ignore Biotech 4:32 p.m. Feb. 7, 2014 - GuruFocus.com
Credit Suisse Reports Ariad's Iclusig is 'Essential Drug' 1:46 p.m. Feb. 7, 2014 - benzinga.com
Mettler-Toledo (MTD) Catches Eye: Stock Jumps 7.7% - Tale of the Tape 9:25 a.m. Feb. 7, 2014 - Zacks.com
Ariad +5.3% AH; activist investor reportedly wants board seats 5:20 p.m. Feb. 6, 2014 - Seeking Alpha
USANA Health Sciences (USNA) Worth Watching: Stock Soars 17.4% - Tale of the Tape 9:46 a.m. Feb. 6, 2014 - Zacks.com
'Mad Money' Lightning Round: We Don't Want Molycorp 6:00 a.m. Feb. 6, 2014 - TheStreet.com
Cramer's Lightning Round - If I Want Security, I Want Palo Alto (2/5/14) 5:57 a.m. Feb. 6, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: A Matter of Distrust 7:51 p.m. Feb. 5, 2014 - TheStreet.com
Ariad Pharma's Executive Stock Giveaway Kills Takeover Hopes 8:00 a.m. Feb. 5, 2014 - TheStreet.com
Investors are betting against Ariad Pharmaceuticals (ARIA), Should You? - Tale of the Tape 6:59 a.m. Feb. 4, 2014 - Zacks.com
Ohr Pharmaceutical (OHRP) Catches Eye: Stock Up 5.0% - Tale of the Tape 9:25 a.m. Feb. 3, 2014 - Zacks.com
Pre-Market Laggard: Ariad Pharmaceuticals (ARIA) 8:16 a.m. Feb. 3, 2014 - TheStreet.com
ARIAD Expands Its Board of Directors with Appointment of Alexander J. Denner, Ph.D. of Sarissa Capital Management 7:35 a.m. Today - BusinessWire - BZX
Facebook to Buy Messaging App WhatsApp; Garmin Ltd. Hits New 1-year High on Earnings 12:29 a.m. Feb. 20, 2014 - ACCESSWIRE
ARIAD to Present at the RBC Capital Markets Healthcare Conference 7:35 a.m. Feb. 19, 2014 - BusinessWire - BZX
ARIAD to Host Conference Call and Webcast Discussion of Fourth Quarter and Year-End 2013 Financial Results on February 25, 2014 7:35 a.m. Feb. 10, 2014 - BusinessWire - BZX
TrendingWallStreet.com Announces Coverage on DDD, ARIA, ENIP, and LATF 12:24 a.m. Feb. 6, 2014 - ACCESSWIRE
ARIAD to Present at the Leerink Swann Global Healthcare Conference 7:35 a.m. Feb. 5, 2014 - BusinessWire - BZX
ARIAD Announces Commercial Agreement for Iclusig (Ponatinib) in Australia 7:35 a.m. Jan. 28, 2014 - BusinessWire - BZX
ARIAD Announces the Commercial Availability of Iclusig (Ponatinib) for Patients with Refractory Philadelphia-Positive Leukemias in the U.S. 7:35 a.m. Jan. 17, 2014 - BusinessWire - BZX
Divestiture, Service Deployment, Executive Promotion, Updated Outlook, and Designation Granted-Research Report on Endo, ARIAD, Align Technology, PAREXEL, and The Medicines Company 8:00 a.m. Jan. 16, 2014 - PR Newswire - PRF
ARIAD and Medinol Announce Initiation of Two Registration Trials of the NIRsupreme™ Ridaforolimus-Eluting Stent for Use in Coronary Artery Disease 7:35 a.m. Jan. 14, 2014 - BusinessWire - BZX
Biologics Selected by ARIAD to Be the Exclusive Specialty Pharmacy Provider for Iclusig (ponatinib) 7:30 a.m. Jan. 13, 2014 - BusinessWire - BZX
Notable Buzzers: Ariad Pharmaceuticals, Twitter Inc, Facebook Inc, Qihoo 360 Technology 11:10 a.m. Jan. 8, 2014 - ACCESSWIRE
Conferences, Completed Acquisitions, and Stock Price Movements - Research Report on Ariad, Salix, Molina, Mednax, and Merrimack 8:00 a.m. Jan. 7, 2014 - PR Newswire
Morning Buzzers: Apple Inc, Plug Power Inc, Ariad Pharmaceuticals, Biodel Inc 10:01 a.m. Jan. 3, 2014 - ACCESSWIRE
ARIAD to Present at the 32nd Annual J.P. Morgan Healthcare Conference 7:34 a.m. Jan. 2, 2014 - BusinessWire
FDA Approvals, Stock Price Movements, and Acquisitions - Research Report on ARIAD, Gentium, Salix Pharmaceuticals, NPS Pharmaceuticals, and MEDNAX 8:00 a.m. Dec. 25, 2013 - PR Newswire
Insider Catalyst Report: Ariad Pharmaceuticals, Advanced Micro Devices, Petroleo Brasileiro Petrobras, Endeavor IP Inc 10:32 a.m. Dec. 23, 2013 - ACCESSWIRE
Stock Price Updates, Executive Appointments, Acquisitions, Orphan Drug Designations, and Preclinical Developments - Research Report on Ariad, Halozyme, DepoMed, Omeros, and BioCryst 8:00 a.m. Dec. 23, 2013 - PR Newswire
Technical Research on Equities: Ariad Pharma, MannKind, Galena Biopharma, and Novavax 8:00 a.m. Dec. 23, 2013 - PR Newswire
Bullish Trend Analysis: Ariad Pharmaceuticals, Federal Home Loan Mortgage Corp, NQ Mobile Inc, Micron Technology 11:02 a.m. Dec. 20, 2013 - ACCESSWIRE
(0)
(0)